Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.66−0.33 (-11.04%)
Close on Nov 17, 2026Market cap $98.90MP/E –Yield –
Armata Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Armata Pharmaceuticals's pe ratio was 1.5× on Jul 29, 2016, against 3.8× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Jul 29, 2016 | 1.5× | −43.1 |
| 2015 | Dec 31, 2015 | 44.6× | +41.3 |
| 2014 | Dec 31, 2014 | 3.2× | – |
See a number that looks wrong?